When should a crystalline essential‑amino‑acid (EAA) infusion be given, what is the recommended dosage and administration schedule, and what monitoring and contraindications should be considered?

Crystalline Essential Amino Acid Infusion

For critically ill ICU patients requiring parenteral nutrition, infuse a balanced crystalline amino acid solution at 1.3-1.5 g/kg/day (based on ideal body weight), supplemented with L-glutamine 0.2-0.4 g/kg/day, administered continuously over 24 hours via central venous access. 1

Indications for Amino Acid Infusion

Crystalline essential amino acid (EAA) infusions are indicated when:

• Parenteral nutrition is required in patients who cannot initiate enteral feeding within 24 hours of ICU admission or injury 1
• Malnutrition is present in critically ill patients, as starvation or underfeeding increases morbidity and mortality 1
• Enteral feeding is inadequate after 2 days—supplementary parenteral nutrition should be considered 1

The evidence strongly supports that critically ill patients with trauma or sepsis achieve optimal protein-sparing effects at these amino acid infusion rates, with no additional benefit observed at higher doses 1.

Dosing and Administration

Standard Dosing Protocol

• General ICU patients: 1.3-1.5 g/kg/day of balanced amino acid mixture 1

  • Trauma patients: optimal at 1.3 g/kg/day 1
  • Septic patients: optimal at 1.5 g/kg/day 1

• L-glutamine supplementation: 0.2-0.4 g/kg/day (or 0.3-0.6 g/kg/day as alanyl-glutamine dipeptide) 1

  • This is a Grade A recommendation with extensive safety data showing no harmful effects at doses of 10-30 g glutamine per 24 hours 1

Special Populations Requiring Adjustment

• Acute renal failure patients (anuric or non-oliguric) on continuous renal replacement therapy or hemodialysis: can achieve positive nitrogen balance with higher nitrogen input of 0.4 g nitrogen/kg/day 1

  • Note: CRRT may increase glutamine loss by 4-7 g/day, further supporting supplementation 1

• Hypocaloric feeding: nitrogen requirements increase by 25-30% 1

• Malnourished critically ill patients: likely require increased nitrogen, though definitive data are limited 1

Administration Details

• Route: Central venous access for high osmolarity mixtures (>850 mOsmol/L) needed to cover full nutritional needs 1
• Duration: Continuous infusion over 24 hours 1
• Formulation: All-in-one bag admixtures containing amino acids, adequate energy (25 kcal/kg/day), lipids, and micronutrients 1
• Energy provision: Must provide adequate calories as fat and glucose to achieve anabolic effects 1

Critical caveat: Combined insulin, glucose, and amino acid administration produces greater anabolic effects than amino acids alone 1. Do not infuse amino acids without adequate energy substrate.

Monitoring Requirements

Metabolic Monitoring

• Blood glucose: Maintain between 4.5-10 mmol/L; hyperglycemia >10 mmol/L increases mortality and infectious complications 1

  • Tighter control (4.5-6.1 mmol/L) shows conflicting mortality data and increases severe hypoglycemia risk 1

• Plasma amino acid levels: Low glutamine levels are associated with worse outcomes 1

• Nitrogen balance: Monitor to assess adequacy of protein provision

Nutritional Status Indicators

• Serum albumin and creatinine levels
• Blood lymphocyte counts
• Anthropometric measurements (when feasible)

These parameters showed significant improvement with parenteral EAA therapy in malnourished patients 2.

Contraindications and Precautions

Absolute Contraindications

• Severe amino acid metabolism disorders
• Hemodynamic instability precluding adequate perfusion

Relative Contraindications and Cautions

• Hepatic encephalopathy: Standard amino acid formulations may worsen symptoms
• Severe azotemia without dialysis: May require dose reduction
• Hyperglycemia: Requires insulin therapy and glucose monitoring 1

Important Clinical Pitfalls

1. Do not exceed optimal dosing: Studies show no additional benefit beyond 1.3-1.5 g/kg/day in trauma/sepsis, and excessive amino acids may worsen outcomes 1

2. Avoid amino acids without energy: The anabolic response requires concurrent adequate caloric provision; amino acid infusion alone is insufficient 1

3. Physical activity matters: Amino acid stimulation of muscle protein synthesis is positively correlated with physical activity, which is impaired in bedridden ICU patients 1

4. Stress hormones blunt response: In critical illness, inflammatory mediators and stress hormones inhibit insulin and amino acid anabolic efficiency—lean tissue loss may be unavoidable despite aggressive support in severe trauma/sepsis 1

5. L-glutamine stability: Use dipeptide forms (alanyl-glutamine or glycyl-glutamine) rather than crystalline L-glutamine, which is poorly soluble and degrades during heat sterilization 1

Practical Implementation Algorithm

1. Assess need: Patient cannot receive enteral nutrition within 24 hours OR enteral feeding inadequate after 2 days
2. Establish central access: For full nutritional support
3. Calculate dose: 1.3-1.5 g/kg ideal body weight/day of balanced amino acids
4. Add glutamine: 0.2-0.4 g/kg/day as dipeptide form
5. Ensure adequate energy: 25 kcal/kg/day with appropriate glucose and lipid provision
6. Initiate gradually: Start at reduced concentration if needed, advance to target over 2-3 days
7. Monitor glucose: Maintain <10 mmol/L, treat hyperglycemia with insulin
8. Adjust for special populations: Increase for renal failure on dialysis, hypocaloric feeding, or malnutrition

The evidence base for glutamine supplementation is particularly robust, with consistent safety data and improved clinical outcomes justifying its status as standard of care in ICU parenteral nutrition 1.